This AI-generated summary is based on the following references:

1. Cornberg M, Sandmann L, Jaroszewicz J, Kennedy P, Lampertico P, Lemoine M, et al. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology. 2025 May [DOI: 10.1016/j.jhep.2025.03.018].

This AI-generated summary is based on the following references:

1. Cornberg M, Sandmann L, Jaroszewicz J, Kennedy P, Lampertico P, Lemoine M, et al. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology. 2025 May [DOI: 10.1016/j.jhep.2025.03.018]

‌

This AI-generated summary is based on the following references:

1. Gebara NY, El Kamari V, Rizk N. HIV-1 elite controllers: an immunovirological review and clinical perspectives. Journal of Virus Eradication. 2019 Jul;5(3):163–6.

‌2. Khan M, Bradshaw D, Brown CS, Haddow J, Patel P, Tosswill JHC, et al. Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays. Open Forum Infectious Diseases. 2023 Mar 1;10(5).

‌3. Giliauskas D. Considerations for the clinical management of HIV elite controllers – The Ontario HIV Treatment Network. 2018.

‌